OFI Invest Asset Management acquired a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 381 shares of the financial services provider’s stock, valued at approximately $38,000.
Several other hedge funds have also bought and sold shares of the business. Private Trust Co. NA boosted its stake in Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares in the last quarter. Phillips Wealth Planners LLC boosted its stake in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. boosted its stake in Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after acquiring an additional 100 shares in the last quarter. TKG Advisors LLC boosted its stake in Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after acquiring an additional 103 shares in the last quarter. Finally, Covestor Ltd lifted its stake in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.
Aflac Stock Down 1.6 %
AFL opened at $106.73 on Tuesday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $79.31 and a 1-year high of $115.50. The company has a market capitalization of $58.34 billion, a PE ratio of 11.12, a PEG ratio of 3.24 and a beta of 0.93. The firm’s 50 day simple moving average is $105.15 and its two-hundred day simple moving average is $107.73.
Insiders Place Their Bets
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.
Wall Street Analysts Forecast Growth
AFL has been the topic of several analyst reports. Keefe, Bruyette & Woods dropped their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. BMO Capital Markets initiated coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price on the stock. Evercore ISI dropped their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Finally, Wells Fargo & Company dropped their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $103.36.
Get Our Latest Stock Report on Aflac
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- What Are Dividend Achievers? An Introduction
- How to Protect Your Portfolio When Inflation Is Rising
- What is the Nasdaq? Complete Overview with History
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- 3 Monster Growth Stocks to Buy Now
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.